BAM
VRTX icon

Berkshire Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.5M Hold
3,370
0.07% 124
2025
Q1
$1.45M Sell
3,370
-274
-8% -$118K 0.07% 123
2024
Q4
$1.6M Sell
3,644
-759
-17% -$334K 0.08% 122
2024
Q3
$2.06M Hold
4,403
0.11% 98
2024
Q2
$2.06M Sell
4,403
-386
-8% -$181K 0.1% 99
2024
Q1
$2M Sell
4,789
-77
-2% -$32.2K 0.11% 89
2023
Q4
$1.98M Sell
4,866
-23
-0.5% -$9.36K 0.11% 86
2023
Q3
$1.7M Sell
4,889
-49
-1% -$17K 0.11% 92
2023
Q2
$1.74M Buy
4,938
+125
+3% +$44K 0.1% 92
2023
Q1
$1.52M Buy
+4,813
New +$1.52M 0.09% 94
2022
Q4
Sell
-4,969
Closed -$1.44M 214
2022
Q3
$1.44M Sell
4,969
-1,162
-19% -$337K 0.1% 87
2022
Q2
$1.73M Sell
6,131
-1,119
-15% -$315K 0.11% 84
2022
Q1
$1.89M Sell
7,250
-2,732
-27% -$713K 0.12% 78
2021
Q4
$2.19M Sell
9,982
-205
-2% -$45K 0.13% 81
2021
Q3
$1.85M Sell
10,187
-65
-0.6% -$11.8K 0.12% 88
2021
Q2
$2.07M Sell
10,252
-1,186
-10% -$239K 0.14% 82
2021
Q1
$2.46M Buy
11,438
+4,129
+56% +$887K 0.18% 70
2020
Q4
$1.73M Buy
7,309
+4,538
+164% +$1.07M 0.13% 82
2020
Q3
$754K Buy
2,771
+360
+15% +$98K 0.07% 98
2020
Q2
$700K Sell
2,411
-2,665
-53% -$774K 0.06% 100
2020
Q1
$1.21M Buy
5,076
+3,311
+188% +$788K 0.13% 91
2019
Q4
$386K Sell
1,765
-49
-3% -$10.7K 0.03% 138
2019
Q3
$307K Hold
1,814
0.03% 174
2019
Q2
$333K Buy
1,814
+351
+24% +$64.4K 0.03% 168
2019
Q1
$269K Hold
1,463
0.02% 194
2018
Q4
$242K Sell
1,463
-400
-21% -$66.2K 0.02% 192
2018
Q3
$359K Hold
1,863
0.03% 174
2018
Q2
$317K Hold
1,863
0.03% 170
2018
Q1
$304K Hold
1,863
0.03% 171
2017
Q4
$279K Sell
1,863
-26
-1% -$3.89K 0.03% 176
2017
Q3
$287K Buy
1,889
+26
+1% +$3.95K 0.03% 160
2017
Q2
$240K Sell
1,863
-269
-13% -$34.7K 0.03% 178
2017
Q1
$233K Buy
+2,132
New +$233K 0.03% 178
2016
Q1
Sell
-1,713
Closed -$216K 168
2015
Q4
$216K Buy
+1,713
New +$216K 0.04% 146
2015
Q3
Sell
-1,813
Closed -$224K 161
2015
Q2
$224K Hold
1,813
0.04% 149
2015
Q1
$214K Sell
1,813
-671
-27% -$79.2K 0.04% 155
2014
Q4
$295K Hold
2,484
0.05% 139
2014
Q3
$279K Hold
2,484
0.05% 141
2014
Q2
$235K Buy
+2,484
New +$235K 0.04% 152